https://www.moneycontrol.com/news/business/earnings/aurobindo-pharma-posts-12-slump-in-q4-net-profit-at-rs-506-crore-revenue-jumps-11-10677291.html
0
0
5/27/23 at 5:11pm
Organization
Moneycontrol
Author
Moneycontrol News
The EBITDA came in at Rs 1,002 crore in Q4FY23, which is three percent higher as against Rs 974.4 crore recorded in the year-ago period.
10 similar articles
Create an account
or login to join the discussion